Literature DB >> 2841783

Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire.

Z Jezek1, B Grab, K M Paluku, M V Szczeniowski.   

Abstract

Human monkeypox is a zoonosis that occurs sporadically in the tropical rainforest of western and central Africa. This article presents the results of epidemiological features of 91 monkeypox patients reported in Bumba zone in northern Zaire during the period 1981 to 1985. Their age ranged from 7 months to 29 years (93% below 15 years of age). 11% of patients had visible smallpox vaccination scars. Deaths occurred sporadically; the overall case-fatality rate was 9%. 91 patients arose in 61 separate outbreaks; 42 of them consisted of only a single case. The source of infection was suspected to be animal for 70 cases, and human for the remaining 21 cases. The illness occurred in all months of the year. There was a considerable clustering of cases in the northern part of the zone. The average annual incidence rate in the observed zone was 0.63 cases per 10,000 population with marked differences in age, time and place. The average annual primary attack rate among unvaccinated individuals (1.7/10,000) sharply contrasted with those vaccinated (0.04/10,000). The secondary attack rate for contacts without vaccination scar (4.3%) differed significantly from those who had been vaccinated in past (0.7%). Many unvaccinated contacts living under conditions of maximal exposure to index cases escaped not only the disease but also infection. The low incidence rate of human monkeypox indicates its limited public health importance even in a well-known enzootic area.

Entities:  

Mesh:

Year:  1988        PMID: 2841783

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  19 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Authors:  Anne W Rimoin; Prime M Mulembakani; Sara C Johnston; James O Lloyd Smith; Neville K Kisalu; Timothee L Kinkela; Seth Blumberg; Henri A Thomassen; Brian L Pike; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Barney S Graham; Pierre Formenty; Emile Okitolonda; Lisa E Hensley; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  Application of the Ibis-T5000 pan-Orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox virus.

Authors:  Rebecca J Grant; Carson D Baldwin; Aysegul Nalca; Scott Zoll; Lawrence B Blyn; Mark W Eshoo; Heather Matthews; Rangarajan Sampath; Chris A Whitehouse
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

4.  Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection.

Authors:  Kevin L Karem; Mary Reynolds; Christine Hughes; Zach Braden; Pragati Nigam; Shane Crotty; John Glidewell; Rafi Ahmed; Rama Amara; Inger K Damon
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

5.  Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation.

Authors:  Erika Hammarlund; Anindya Dasgupta; Clemencia Pinilla; Patricia Norori; Klaus Früh; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

6.  Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus.

Authors:  Jason Kindrachuk; Ryan Arsenault; Anthony Kusalik; Kristen N Kindrachuk; Brett Trost; Scott Napper; Peter B Jahrling; Joseph E Blaney
Journal:  Mol Cell Proteomics       Date:  2011-12-28       Impact factor: 5.911

7.  Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin.

Authors:  Amira A Roess; Benjamin P Monroe; Eric A Kinzoni; Seamus Gallagher; Saturnin R Ibata; Nkenda Badinga; Trolienne M Molouania; Fredy S Mabola; Jean V Mombouli; Darin S Carroll; Adam MacNeil; Noelle A Benzekri; Cynthia Moses; Inger K Damon; Mary G Reynolds
Journal:  PLoS Negl Trop Dis       Date:  2011-10-18

8.  In vitro inhibition of monkeypox virus production and spread by Interferon-β.

Authors:  Sara C Johnston; Kenny L Lin; John H Connor; Gordon Ruthel; Arthur Goff; Lisa E Hensley
Journal:  Virol J       Date:  2012-01-06       Impact factor: 4.099

9.  Effects of georeferencing effort on mapping monkeypox case distributions and transmission risk.

Authors:  R Ryan Lash; Darin S Carroll; Christine M Hughes; Yoshinori Nakazawa; Kevin Karem; Inger K Damon; A Townsend Peterson
Journal:  Int J Health Geogr       Date:  2012-06-27       Impact factor: 3.918

10.  Spectrum of infection and risk factors for human monkeypox, United States, 2003.

Authors:  Mary G Reynolds; Whitni B Davidson; Aaron T Curns; Craig S Conover; Gregory Huhn; Jeffrey P Davis; Mark Wegner; Donita R Croft; Alexandra Newman; Nkolika N Obiesie; Gail R Hansen; Patrick L Hays; Pamela Pontones; Brad Beard; Robert Teclaw; James F Howell; Zachary Braden; Robert C Holman; Kevin L Karem; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.